Steven Chapman Net Worth

The estimated Net Worth of Steven Leonard Chapman is at least $94.4 million dollars as of 15 August 2024. Mr. Chapman owns over 5,583 units of Natera Inc stock worth over $24,853,919 and over the last 14 years he sold NTRA stock worth over $63,378,226. In addition, he makes $6,200,910 as President, Chief Executive Officer et Director at Natera Inc.

Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!

Sign up

Already have an account? Sign in

Mr. Chapman NTRA stock SEC Form 4 insiders trading

Steven has made over 109 trades of the Natera Inc stock since 2010, according to the Form 4 filled with the SEC. Most recently he sold 5,583 units of NTRA stock worth $663,875 on 15 August 2024.

The largest trade he's ever made was selling 139,340 units of Natera Inc stock on 16 January 2020 worth over $4,876,900. On average, Steven trades about 14,973 units every 39 days since 2010. As of 15 August 2024 he still owns at least 200,710 units of Natera Inc stock.

You can see the complete history of Mr. Chapman stock trades at the bottom of the page.

Steven Chapman biography

Steven (Steve) Leonard Chapman serves as President, Chief Executive Officer, Director of the Company. Mr. Chapman has been with our company since December 2010, serving as our Chief Operating Officer from July 2017 to January 2019; our Chief Commercial Officer from August 2016 to July 2017; our Senior Vice President, Commercial Operations from January 2014 to August 2016; and Vice President, Sales from December 2010 to January 2014. Prior to joining our company, Mr. Chapman worked at Genzyme Genetics Corp., a biotechnology company, from 2003 to 2010. Mr. Chapman holds a Bachelor of Science in Microbiology, Immunology and Molecular Genetics from University of California, Los Angeles. Our board of directors believes that Mr. Chapman is qualified to serve as a director based on his experience in various roles at our company and his experience in the biotechnology field.

What is the salary of Steven Chapman?

As the President, Chief Executive Officer et Director of Natera Inc, the total compensation of Steven Chapman at Natera Inc is $6,200,910. There are no executives at Natera Inc getting paid more.

How old is Steven Chapman?

Steven Chapman is 41, he's been the President, Chief Executive Officer et Director of Natera Inc since 2019. There are 14 older and 1 younger executives at Natera Inc. The oldest executive at Natera Inc is Herman Rosenman, 72, who is the Independent Director.

What's Steven Chapman's mailing address?

Steven's mailing address filed with the SEC is C/O NATERA, INC., 13011 MCCALLEN PASS BUILDING A SUITE 100, AUSTIN, TX, 78753.

Insiders trading at Natera Inc

Over the last 14 years, insiders at Natera Inc have traded over $290,138,276 worth of Natera Inc stock and bought 2,046,493 units worth $38,018,986 . The most active insiders traders include Matthew Rabinowitz, James Healy et Roelof Botha. On average, Natera Inc executives and independent directors trade stock every 9 days with the average trade being worth of $3,415,231. The most recent stock trade was executed by Steven Leonard Chapman on 15 August 2024, trading 5,583 units of NTRA stock currently worth $663,875.

What does Natera Inc do?

natera is a san carlos, ca-based company that is driven by a passion for elevating the science and utility of prenatal testing. the advent of the information age has created a paradigm shift in the fields of computing and informatics. surprisingly, medical diagnostics have been slow to integrate these advances into genetic testing. until natera. from conception to delivery, natera is pioneering next-generation accuracy and reliability in preconception and prenatal genetic testing services, enabling couples to be informed about their pregnancy each step of the way. the company offers a wide range of tests from preimplantation genetic diagnosis (pgd) for ivf to breakthrough advances in the field of non-invasive prenatal testing (nipt). using advances from the human genome project and powered by sophisticated proprietary bioinformatic algorithms, natera’s comprehensive portfolio of tests, proven science, and experienced genetic counseling services deliver the most accurate results in the

Complete history of Mr. Chapman stock trades at Natera Inc

Natera Inc executives and stock owners

Natera Inc executives and other stock owners filed with the SEC include:

• Steven Chapman,
  President, Chief Executive Officer, Director
• Robert Schueren,
  Chief Operating Officer
• Michael Brophy,
  Chief Financial Officer
• Matthew Rabinowitz,
  Executive Chairman of the Board, Co-Founder
• Steve Leonard Chapman,
  CEO, Pres & Director
• Jonathan Sheena,
  Co-Founder, Chief Technology Officer, Director
• Robert A. Schueren,
  Chief Operating Officer
• Steve Chapman,
  CEO, Pres & Director
• Michael Brophy,
  Chief Financial Officer
• Rowan Chapman,
  Independent Director
• Dr. Matthew Rabinowitz Ph.D.,
  Co-Founder & Exec. Chairman
• Gail Marcus,
  Independent Director
• Roelof Botha,
  Lead Independent Director
• Todd Cozzens,
  Independent Director
• James Healy,
  Independent Director
• Herman Rosenman,
  Independent Director
• Roy Baynes,
  Independent Director
• Jonathan Sheena,
  Co-Founder & Director
• Monica Bertagnolli,
  Independent Director
• Rishi Kacker,
  Chief Technology Officer
• Paul Greenland,
  VP of Corp. Marketing
• Dr. Ramesh Hariharan,
  VP of Marketing & Medical Education
• Phil Grinnell,
  VP of Sales
• Daniel Rabinowitz L.L.M., LL.M.,
  Sec. & Gen. Counsel
• Eric A. Evans,
  Chief Scientific Officer
• John Steuart,
  Director
• John Fesko,
  PRESIDENT, CHIEF BUS. OFFICER
• Creek Ventures L P Claremon...,
  
• Solomon Moshkevich,
  PRESIDENT, CLINICALDIAGNOSTICS
• Creek Ventures L P Claremon...,
  
• Creek Ventures L P Claremon...,
  
• Venture Partners Viii Lp Li...,
  
• Xii Management Llcsequoia C...,
  
• Daniel Rabinowitz,
  SEC. AND CHIEF LEGAL OFFICER
• Herm Rosenman,
  
• Brinkley Ruth Williams,